The Department of Health acknowledges concerns about assessing self-harm risk and providing safety advice, referencing existing government action plans, NICE guidance, and GMC guidance on confidentiality and information sharing. (AI summary)
View full response
The Government has made a clear commitment in the Health and Social Care Act 2012 to give mental health equal priority with physical health This commitment is at the heart of Closing the Gap: Priorities for essential change in mental health; the Government'$ action plan for mental health which was launched by Nick on 2Oth January 2014. This sets out twenty five areas where people can expect to see and experience the fastest changes. This document bridges the gap between our longer-term ambition and shorter term action; It sets out our expectations and shows how changes in local service planning and delivery will make a difference in the next two O three years to the lives of people with mental health. Taking your points in turn: guidance on risk assessment is included in clinical guidelines (CG133 Self-harm: longer-term management) produced by the National Institute for Health and Clinical Excellence (NICE), and issued in November 2011, It is worth quoting a relevant extract; The guidelines state: A risk assessment is a detailed clinical assessment that includes the evaluation of a wide range of biological, social and psychological factors that are relevant to the individual and, in the judgement of the healthcare professional conducting the assessment, relevant to future risks; including suicide and self-harm. Risk assessment tools and scales are usually checklists that can be completed and scored by a clinician, or sometimes the service user, depending on the nature of the tool or scale They are designed to give a crude indication of the level ofrisk (for example, high o1 low) ofa particular outcome, most often suicide. The strong advice is, however; that cannot be used to predict future suicide O1 repetition of self-harm; Turning to confidentiality, there are clearly times when health care professionals, in dealing with a person at risk of suicide, may need to inform the family about aspects of risk to help keep the patient safe. I agree it is crucial that we address any confusion about how information can be shared That is why the Department of Health is already working with Royal Colleges and professional organisations to agree a consensus statement designed to promote greater sharing of information with the aim of preventing suicide, within the context of the relevant law_ We published this on 17 January at: gov uklgovernment/uploads/system /uploadslattachment_data/file/2742 92/Consensus_statement on information_sharing pdf Relevant guidance already exists on justifications for breaching patient confidentiality: The General Medical Council's Guidance to Doctors on Clegg they https / Iwww
Department of Health Confidentiality covers disclosures in the public interest and disclosing personal information without consent and specifically states: "Disclosure in the public interest may be justified when: failure to disclose information may put the patient, or someone else, at risk of death or serious harm, Or' (b) disclosure is likely to help in the prevention, detection or prosecution of a serious crime. In addition, the Department of Health published supplementary guidance to the NHS Confidentiality Code of Practice (November 2010, Ref 13912) on disclosing confidential information when there is a interest justification to do s0 and makes clear to healthcare professionals when it is appropriate to disclose personal information_ Finally, in relation to your suggestion of issuing guidance to doctors about prescribing medication to mental health patients that carries an increased risk of self-harm; there is currently comprehensive guidance on prescribing produced by a number of bodies including NICE; the General Medical Council and the British Medical Association. The guidance available specifically addresses how to assess the risk of prescribing a particular medication for individuals at risk of self-harm. Guidance often includes advice directed to patients and carers You mention that a medication that carried an increased risk of self-harm was involved in this case, but the name is not given. If you could supply this information we might be able to provide further advice about this aspect of the case. [ hope that this response is helpful and I am grateful to you for bringing the circumstances 0f Mr Ladak-Ebrahim'$ death to my attention. k~ Au JEREMY HUNT public